Enteral stents market is a leading non-vascular stents market. This market includes esophageal stents, gastro duodenal stents, and colonic stents, and is divided into three segments: fully covered enteral stents, partially covered enteral stents, and non-covered enteral stents. As a whole, the enteral stents market is increasing, primarily due to globally rising cancer rates, specifically esophageal, stomach, pancreatic, and colorectal cancers, and by an increased awareness of stenting as a palliative treatment.
Enteral stents are a palliative treatment option for constrictions caused primarily by various cancers. The primary cancers which cause constrictions requiring the use of enteral stents are esophageal cancer, gastric cancer, pancreatic cancer, and colorectal cancer. There are three primary enteral stents; the covered enteral stent, the partially covered enteral stents, and the non-covered enteral stent.
North American market for enteral stents, which encompasses three countries and includes esophageal stents, gastrointestinal stents, and colonic stents, was valued at approximately $46.8M in 2016. The market is expected to grow at a CAGR of 4.2%, to reach a valuation of $62.3M in 2023.
The key drivers of this market during the forecast period are:
- Increased cancer rates driven by an increased intake of toxins such as tobacco and alcohol.
- Increase in diseases such as diabetes and obesity.
- Development of stenting technology.
Globally, fully covered stents are the largest market. They tend to be preferred over partially covered and non-covered enteral stents, especially in the case of esophageal stents, as they have the lowest risk of tumor or tissue ingrowth.
There are three key players in the international enteral stents market. Boston Scientific is the leading company in the enteral stents market thanks to an extensive product line and a presence in all segments of the enteral stents market. Its presence was further strengthened by the acquisition of EndoChoice, a former smaller player in the enteral stents market. The other two key players in the enteral stents market are Cook Medical and Taewoong Medical. Cook Medical has established a strong presence despite a small product line, while Taewoong Medical has a more extensive product portfolio.
The report "MediPoint: Enteral Stents - North America Forecast and Market Analysis" examines the enteral stents market in three major North American markets: Canada, Mexico, and the US. This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed products, current players, as well as market outlooks in the North American market.
Companies mentioned in this report: Boston Scientific, EndoChoice, Taewoong Medical, Cook Medical. Merit Medical, Leufen Medical, ELLA-CS, M.I.Tech.
2 Executive Summary
2.2 Market Dynamics
2.3 Key Players
2.4 Future Outlook
3.2 Related Reports
3.3 Upcoming Related Reports
4 Market Outlook
4.1 Procedure Trends
4.2 Pricing Trends
4.3 Revenue Trends
4.4 Company Share Analysis
5 Market Insights
5.1 North America
6 Competitive Assessment
6.1 Boston Scientific
6.1.2 Portfolio Assessment
6.1.3 Deal Analysis
6.1.4 Competitive Positioning
6.2 Cook Medical
6.2.2 Portfolio Assessment
6.2.3 Competitive Positioning
6.3 Taewoong Medical
6.3.2 Portfolio Assessment
6.3.3 Competitive Positioning
6.4 Other Players
7.3.3 Secondary Research
7.3.4 Forecasting Methodology
7.3.5 Primary Research Summary
7.4 About the Authors
7.4.2 Global Head of Medical Devices
7.5 About MediPoint
List of Tables
Table 1: Key Metrics in the North America Market
Table 2: North America Enteral Stenting Procedure Volume Forecast, 2014-2023
Table 3: North America Enteral Stents Average Selling Price ($) Forecast, 2014-2023
Table 4: North America Enteral Stents Sales Forecast ($M), 2014-2023
Table 5: North America Company Share Analysis, 2016
Table 6: Product Portfolio - Boston Scientific
Table 7: Product Portfolio - Cook Medical
Table 8: Product Portfolio -Taewoong Medical
Table 9: Other Players Assessment
List of Figures
Figure 1: Enteral Stents Sales for North America by Country, 2016 and 2023